Question 1

What is Yuhong Li?

Accepted Answer

Yuhong Li is a Person.

Question 2

How often does Yuhong Li appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 33 articles.

Question 3

When was Yuhong Li first tracked by Ergen?

Accepted Answer

First tracked on May 25, 2026.

Question 4

When was Yuhong Li last mentioned in news?

Accepted Answer

Last active on Jun 08, 2026.

Question 5

What is Yuhong Li's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Yuhong Li in global news coverage?

Accepted Answer

Attention score of 7, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Yuhong Li?

Accepted Answer

ASCO 2026 Oncology Research Presentations (May 25, 2026, 33 articles).

Question 8

How did the "ASCO 2026 Oncology Research Presentations" event impact Yuhong Li?

Accepted Answer

Professor Yuhong Li co-led the Phase III PROTECT study, which demonstrated the efficacy of a new antiemetic drug for chemotherapy-induced nausea and vomiting.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.